Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celestial-1: FE999302 in Women Undergoing Controlled Ovarian Stimulation
NCT06466486Phase 1Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 5
01
Overview
Phase 1, randomised, double-blind trial of choriogonadotropin beta in infertility (6 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Number of good-quality blastocysts. Started Jun 2024; status: terminated.
02
Drugs
choriogonadotropin beta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06466486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06466486.